Therapy resistant depressions. 1979

C Pérez de Francisco

UI MeSH Term Description Entries
D011612 Psychosurgery Treatment of chronic, severe and intractable psychiatric disorders by surgical removal or interruption of certain areas or pathways in the brain, especially in the prefrontal lobes. Gyrectomy,Leucotomy,Leukotomy,Lobotomy,Topectomy,Gyrectomies,Leucotomies,Leukotomies,Lobotomies,Psychosurgeries,Topectomies
D003863 Depression Depressive states usually of moderate intensity in contrast with MAJOR DEPRESSIVE DISORDER present in neurotic and psychotic disorders. Depressive Symptoms,Emotional Depression,Depression, Emotional,Depressive Symptom,Symptom, Depressive
D004351 Drug Resistance Diminished or failed response of an organism, disease or tissue to the intended effectiveness of a chemical or drug. It should be differentiated from DRUG TOLERANCE which is the progressive diminution of the susceptibility of a human or animal to the effects of a drug, as a result of continued administration. Resistance, Drug
D004565 Electroconvulsive Therapy Electrically induced CONVULSIONS primarily used in the treatment of severe AFFECTIVE DISORDERS and SCHIZOPHRENIA. Convulsive Therapy, Electric,ECT (Psychotherapy),Electroshock Therapy,Shock Therapy, Electric,Convulsive Therapies, Electric,Electric Convulsive Therapies,Electric Convulsive Therapy,Electric Shock Therapies,Electric Shock Therapy,Electroconvulsive Therapies,Electroshock Therapies,Shock Therapies, Electric,Therapies, Electric Convulsive,Therapies, Electric Shock,Therapies, Electroconvulsive,Therapies, Electroshock,Therapy, Electric Convulsive,Therapy, Electric Shock,Therapy, Electroconvulsive,Therapy, Electroshock
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000928 Antidepressive Agents Mood-stimulating drugs used primarily in the treatment of affective disorders and related conditions. Several MONOAMINE OXIDASE INHIBITORS are useful as antidepressants apparently as a long-term consequence of their modulation of catecholamine levels. The tricyclic compounds useful as antidepressive agents (ANTIDEPRESSIVE AGENTS, TRICYCLIC) also appear to act through brain catecholamine systems. A third group (ANTIDEPRESSIVE AGENTS, SECOND-GENERATION) is a diverse group of drugs including some that act specifically on serotonergic systems. Antidepressant,Antidepressant Drug,Antidepressant Medication,Antidepressants,Antidepressive Agent,Thymoanaleptic,Thymoanaleptics,Thymoleptic,Thymoleptics,Antidepressant Drugs,Agent, Antidepressive,Drug, Antidepressant,Medication, Antidepressant

Related Publications

C Pérez de Francisco
July 1974, Pharmakopsychiatrie, Neuro-Psychopharmakologie,
C Pérez de Francisco
January 1979, International pharmacopsychiatry,
C Pérez de Francisco
May 1974, Pharmakopsychiatrie, Neuro-Psychopharmakologie,
C Pérez de Francisco
May 1974, Pharmakopsychiatrie, Neuro-Psychopharmakologie,
C Pérez de Francisco
January 1979, International pharmacopsychiatry,
C Pérez de Francisco
May 1974, Pharmakopsychiatrie, Neuro-Psychopharmakologie,
C Pérez de Francisco
January 1975, International journal of psychiatry in medicine,
C Pérez de Francisco
July 1974, Pharmakopsychiatrie, Neuro-Psychopharmakologie,
C Pérez de Francisco
January 1988, Revue de l'infirmiere,
C Pérez de Francisco
November 2014, Psychiatria Danubina,
Copied contents to your clipboard!